Guidelines for radioiodine therapy of differentiated thyroid cancer
| Autor: | Wim J.G. Oyen, Markus Dietlein, Jan Tennvall, Michael Lassmann, S. E. Clarke, Markus Luster, Emilio Bombardieri, P. Lind |
|---|---|
| Rok vydání: | 2008 |
| Předmět: |
medicine.medical_specialty
MEDLINE Aetiology screening and detection [ONCOL 5] Scintigraphy Iodine Radioisotopes Translational research [ONCOL 3] medicine Humans Radiology Nuclear Medicine and imaging Thyroid Neoplasms Intensive care medicine Thyroid cancer medicine.diagnostic_test business.industry Thyroid Immunotherapy gene therapy and transplantation [UMCN 1.4] Radioiodine therapy General Medicine medicine.disease Patient counselling Pathogenesis and modulation of inflammation [N4i 1] medicine.anatomical_structure Expert opinion Practice Guidelines as Topic Radiation Oncology Functional Imaging [UMCN 1.1] Nuclear Medicine Radiopharmaceuticals business Nuclear medicine |
| Zdroj: | European Journal of Nuclear Medicine and Molecular Imaging, 35, 1941-59 European Journal of Nuclear Medicine and Molecular Imaging, 35, 10, pp. 1941-59 |
| ISSN: | 1619-7070 |
| Popis: | Contains fulltext : 70127.pdf (Publisher’s version ) (Closed access) INTRODUCTION: The purpose of the present guidelines on the radioiodine therapy (RAIT) of differentiated thyroid cancer (DTC) formulated by the European Association of Nuclear Medicine (EANM) Therapy Committee is to provide advice to nuclear medicine clinicians and other members of the DTC-treating community on how to ablate thyroid remnant or treat inoperable advanced DTC or both employing large 131-iodine ((131)I) activities. DISCUSSION: For this purpose, recommendations have been formulated based on recent literature and expert opinion regarding the rationale, indications and contraindications for these procedures, as well as the radioiodine activities and the administration and patient preparation techniques to be used. Recommendations also are provided on pre-RAIT history and examinations, patient counselling and precautions that should be associated with (131)I iodine ablation and treatment. Furthermore, potential side effects of radioiodine therapy and alternate or additional treatments to this modality are reviewed. Appendices furnish information on dosimetry and post-therapy scintigraphy. |
| Databáze: | OpenAIRE |
| Externí odkaz: |
|
Full text from SpringerLink